Research.Patient.info
Locally Advanced Extraskeletal Myxoid Chondrosarcoma research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE2
Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
This study looks at treating advanced soft tissue sarcoma with a combination of two immunotherapy drugs (ipilimumab and nivolumab), alone or with an additional drug called cabozantinib, to see which works best.
United States · Canada - recruitingPHASE3
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
This study looks at combining immunotherapy (pembrolizumab) with chemotherapy (doxorubicin) for certain aggressive sarcomas. It compares this combination to chemotherapy alone, hoping to find a better way to stop the cancer from growing and spreading.
United States · Canada · Puerto Rico